Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in the top 5,000 websites in the
Chat real-time with other investors about this UCOI news release,
by clicking this link: http://www.stockwire.com/UCOI
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=UCOI
Unico, Incorporated (OTCBB: UCOI), up 14% on 29 million shares, a natural resource company in the precious metals mining sector, yesterday announced that its wholly owned subsidiary Deer Trail Mining Company has submitted a correspondence notifying the U.S. Mine Safety and Health Administration (MSHA) that the company has contracted with Atlas Fausett Contracting, a division of Atlas Mining, for underground mine maintenance work including portal and stope rehabilitation at the Deer Trail Mine in Marysvale, Utah.
----------------------------------------------------------
Chat real-time with other investors about this ORCL news release,
by clicking this link: http://www.stockwire.com/ORCL
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=ORCL
Oracle Corporation (Nasdaq: ORCL), up .89% on 18 million shares, yesterday announced strong global customer momentum for Siebel CRM 8. With over 41 percent of the current Siebel CRM install base downloading Siebel CRM 8 since January 2007, leading organizations anticipate increased revenue and performance through the adoption of Siebel 8. Siebel 8 enables customer- driven business transformation with real-time insight at the moment of customer interaction, while helping to accelerate revenue growth through better-informed decisions. Customers leveraging Siebel 8 include: Bayer Healthcare, Club Car (a division of Ingersoll Rand), Alberta Health, Export Development Canada, Intuit, Deutsche Krankenversicherung (DKV) and La Commission de la sante et de la securite du travail (CSST) Canada. In addition, many current Siebel CRM customers are actively upgrading to Siebel 8, including: Horizon Blue Cross Blue Shield of New Jersey, The Motorists Insurance Group and Australian Financial Group (AFG).
----------------------------------------------------------
Chat real-time with other investors about this RAVI news release,
by clicking this link: http://www.stockwire.com/RAVI
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=RAVI
Raven Moon Entertainment, Inc. (OTCBB: RAVI), even on 18 million shares, announced yesterday that its CEO Joey DiFrancesco was interviewed on www.wallst.net yesterday and said that, "Because Gina D(R) is a real team player, the company has cut 80% of its annual talent costs from $1,800,000 to $360,000" and has deleted the use of S-8 stock as compensation except for legal services. He also talked about the 2nd quarter 10QSB report to the SEC on 8/14/2007. Total revenues for the six-months ended June 30, 2007 and 2006 were $497,198 and $1,556, respectively, an increase of $495,642. The Company has begun to generate revenue from the sale of client services, which amounted to $491,000 during the quarter ended June 30, 2007. The Company is also experiencing increased sales of toys and musical products, the result of its production efforts over the last several years.
----------------------------------------------------------
Chat real-time with other investors about this CHINA news release,
by clicking this link: http://www.stockwire.com/CHINA
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=CHINA
CDC Corporation (Nasdaq: CHINA), up 8% on 12 million shares, a business unit of CDC Corporation and pioneer of the "free-to-play, pay for merchandise" model for online games in China, yesterday announced key performance metrics for certain of its commercially available games in China.
----------------------------------------------------------
Chat real-time with other investors about this MGEN news release,
by clicking this link: http://www.stockwire.com/MGEN
To view in-depth research, click the following link:
http://www.stockwire.com/detailed/analysis.php?company=MGEN
Med Gen Inc (OTCBB: MGEN), up 25% on 8 million shares, a manufacturer of nationally branded OTC healthier life products and speciality financial services, released the company's financial gains yesterday. The company collected unaudited revenue of USD1.7m for the year ending 30 September 2007, a growth of 598% over the prior year. The company announced that liquidity in the form of cash on hand or cash equivalents exceeded USD1.1m. Additionally, the company reported that the Therapedic Innersole commercials that have been testing during the month of August and September have not produced sufficient revenue in their current format and have been discontinued until a new format can be developed.
----------------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to: http://www.stockwire.com .
About Stockwire:
Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at www.sec.gov and/or the National Association of Securities Dealers ("NASD") at www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page. www.sec.gov/edgar.shtml
Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at http://www.stockwire.com/disclaimer_profiles.htm .
The Stockwire Group .
512.358.8440 .
info@stockwire.com .
